Cancer Research and Treatment · 2018 · 15 citations · 6 references
MedicineOncologyPharmacologyCancer GeneticsMetastasisMolecular OncologyCancer ProgressionLung CancerMalignant NeoplasmsOncogene MutationsTherapeutic ResistanceTyrosine Kinase InhibitorsAcquired Resistance MechanismsAllele FrequencyEgfr InhibitionMetastatic Liver TumorsNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentResistance To Tyrosine Kinase InhibitorsTherapeutic Tyrosine Kinase Inhibitors
Epidermal growth factor receptor (EGFR)‒tyrosine kinase inhibitors (TKIs) are effective clinical therapeutics for EGFR-mutant non-small cell lung cancer (NSCLC). Osimertinib, a thirdgeneration EGFR TKI, has proven effective against T790M mutations. However, the vast majority of patients acquire resistance following successful treatment. A 59-year-old female patient with metastatic NSCLC developed resistance after 43 weeks of osimertinib. CancerSCAN of the metastatic liver lesion revealed a EGFR C797G mutation at an allele frequency of 72%, a preexisting T790M mutation (73%) in cis and an exon 19 deletion (87%). Another 53-year-old female patient developed systemic progression after 10 months of osimertinib. CancerSCAN of the lung biopsy identified an EGFR L718Q mutation at an allele frequency of 7%, concomitant PIK3CA E545K (12.90%) and preexisting EGFR L858R (38%), but loss of the T790M mutation. The heterogeneity of osimertinib resistance mechanisms warrants further investigation into novel or combination agents to overcome the rare acquired resistances.
6
EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors
Dalia Ercan, Hwan Geun Choi, Cai‐Hong Yun et al. · Clinical Cancer Research · 2015 · 355 citations · Full text
Medicine, Oncology, Pharmacology +14
Prevalence and detection of low-allele-fraction variants in clinical cancer samples
Hyun‐Tae Shin, Yoon‐La Choi, Jae Won Yun et al. · Nature Communications · 2017 · 198 citations · Full text
Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng‐Sen Tseng et al. · Cancer Research and Treatment · 2018 · 63 citations · Full text